Search
for

    Sort by

    Research 31–60 of 39

    1. SARGRAMOSTIN 2004
    2. Scleroderma and L-tryptophan: A possible explanation of the eosinophilia-myalgia syndrome Journal of The American Academy of Dermatology · 1990 · 21 citations
    3. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology Best Practice & Research in Clinical Obstetrics & Gynaecology · 2004 · 131 citations
    4. Eosinophilic Fasciitis Associated With Tryptophan Ingestion Archives of dermatology · 1991 · 20 citations
    5. Diseases of the Hair and Nails Medical Clinics of North America · 2009 · 4 citations
    6. The eosinophilia-myalgia syndrome Clinics in Dermatology · 1994 · 4 citations
    7. A ALOPECIA AREATA E SUA RELAÇÃO COM A GEOGRAFIA E A PROMOÇÃO DA SAÚDE Hygeia - Revista Brasileira de Geografia Médica e da Saúde · 2017 · 1 citations
    8. ENZYMES British journal of pharmacology · 2011 · 1 citations
    9. Enzymes British Journal of Pharmacology · 2008
    10. Parkinson's disease and skin 2021 · 28 citations
    11. Agglomerative clustering-based drugs graded for the risk signals of drug-induced cognitive disorder: a study on the FAERS database Therapeutic Advances in Drug Safety · 2026
    12. Mutation in 5′ upstream region of <i>GCH</i> I gene causes familial dopa-responsive dystonia Movement Disorders · 2011 · 7 citations
    13. Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach Acta Neurologica Belgica · 2019 · 12 citations
    14. Drugs that affect autonomic functions or the extrapyramidal system Side effects of drugs annual · 2009
    15. Spectrum and signals of medication-associated cognitive disorder: a comprehensive disproportionality analysis with cross-database validation Frontiers in Pharmacology · 2026
    16. Drug Reactions Affecting Hair: Diagnosis Dermatologic Clinics · 2007 · 85 citations
    17. Medication-Induced Repigmentation of Gray Hair: A Systematic Review Skin appendage disorders · 2019 · 28 citations
    18. DRUG‐ASSOCIATED ALOPECIA International Journal of Dermatology · 1995 · 63 citations
    19. Skin disorders in Parkinson&rsquo;s disease: potential biomarkers and risk factors Clinical, cosmetic and investigational dermatology · 2017 · 47 citations
    20. Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease Movement Disorders · 2011 · 47 citations
    21. A preliminary study of finasteride in Tourette syndrome Movement Disorders · 2011 · 46 citations
    22. Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up Movement Disorders · 2011 · 39 citations
    23. Pathological findings in a case of stiff person syndrome with anti‐GAD antibodies Movement Disorders · 2011 · 17 citations
    24. Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy Movement Disorders · 2011 · 4 citations
    25. The Neurobiology of Sexual Function Archives of General Psychiatry · 2000 · 393 citations
    26. Interpenetrating gelatin/sodium alginate hydrogel with controlled PRP lysate delivery for accelerating diabetic wound healing with reduced scarring RSC Advances · 2026
    27. Farmácia Sanches - Leiria e nos Serviços Farmacêuticos do Hospital Lusíadas - Porto Open Repository of the University of Porto (University of Porto) · 2025
    28. Preparation and evaluation of minoxidil nanoemulgel topical formulations. 2024
    29. Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas British Journal of Dermatology · 2003 · 68 citations
    30. Drug-Induced Hair Disorders Current Drug Safety · 2006 · 40 citations